Health
Most adults with moderate-to-severe ulcerative colitis may be ineligible for randomized controlled trials
Sandra Elmasry, M.D., from Mayo Clinic Arizona in Scottsdale, and colleagues conducted a retrospective cohort study involving adults with moderate-to-severe UC seen between January 2022 and February 2023 to examine contemporary clinical…
AI Summary
A study published online on Aug. 4 in Crohn’s & Colitis 360 found that over 50 % of real‑world adult patients with moderate‑to‑severe ulcerative colitis do not meet eligibility criteria for existing randomized controlled trials.
Read full article on Medical XpressAI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Parkinson's an unexpected and unpredictable journey for Pacific PeoplesContinue reading
- Current shingles vaccine linked to lower risk of coronary heart disease, stroke and heart failureContinue reading
- Primate-specific DNA change reveals a new link to dementia-related neurodegenerationContinue reading
- Listen to the Latest ‘KFF Health News Minute’Continue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow